Is GINA Worth the Wait?

Abstract:     
It has been pending in Congress for twelve years, despite the support of the last Presedential Adminstrations and the National Institutes of Health. It has been the subject of extensive lobbying by acedemic medical centers, pharmaceutical and biotech companies, genetic advocacy groups, and civil rights organizations. It has overcome vehement objections by employers and insurers. Its final passage however, has been thwarted by a few Congressional leaders, who have prevented enactment despite overwhelming bi-patisian support in both houses of Congress.

Accepted Paper Series